CNBX Pharmaceuticals CNBX
OTC CNBX
$0.00 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

CNBX Pharmaceuticals Inc. (CNBX) Income towards Parent Company (2011 - 2026)

Updated

CNBX Pharmaceuticals (CNBX) recorded Income towards Parent Company of -$154,165 in fiscal Q3 2026 (quarter ended May 31, 2026), compared with -$59,727 a year earlier.

Analysis

CNBX Pharmaceuticals Inc. (CNBX) Income towards Parent Company (2011 - 2026) Analysis & Trends

On a TTM basis, CNBX Pharmaceuticals' Income towards Parent Company came in at -$462,091 as of May 31, 2026; for FY2025 (ended Aug 31, 2025), it was -$313,976.

  • Across earlier fiscal years, Income towards Parent Company came in at -$695,198 in FY2024, -$3.71 million in FY2023, -$3.72 million in FY2022 and -$3.19 million in FY2021.
  • The fiscal Q3 2026 figure is the lowest quarterly Income towards Parent Company since fiscal Q2 2024.
  • Per Business Quant, the preceding three fiscal quarters came in at -$44,098 (Q2 2026), -$113,719 (Q1 2026) and -$150,109 (Q4 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 -154,165.00
Feb 28, 2026 -44,098.00
Nov 30, 2025 -113,719.00
Aug 31, 2025 -150,109.00
May 31, 2025 -59,727.00
Feb 28, 2025 -69,788.00
Nov 30, 2024 -34,352.00
Aug 31, 2024 -60,584.00
May 31, 2024 -130,632.00
Feb 29, 2024 -325,459.00
Nov 30, 2023 -178,523.00
Aug 31, 2023 -573,554.00
May 31, 2023 -154,690.00
Feb 28, 2023 -2.62 Mn
Nov 30, 2022 -357,669.00
Aug 31, 2022 -479,707.00
May 31, 2022 -681,652.00
Feb 28, 2022 -1.24 Mn
Nov 30, 2021 -1.32 Mn
Aug 31, 2021 -681,150.00
API Access

CNBX Pharmaceuticals Inc. Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=CNBX&period=max&api_key=YOUR_API_KEY